The overall objective of this study is to examine the neuroendocrine differences in adolescent subjects (13-18 years) with major depression (MDD), and normal controls following a challenge test with a serotonergic (5-HT) probe, mCPP (M-chlorophenylpiperazine). Following the challenge with mCPP, subjects with diagnosis of MDD would be recruited in a double blind placebo control study of fluoxetine.
Showing the most recent 10 out of 1380 publications